Dear Colleague: It is a very exciting time for innovation in the life sciences industry, especially in the areas of DNA sequencing, gene therapies, and diagnostics. These inventions, however, are only as exciting as their potential value and benefits, which, in light of the ever evolving § 101 standard, may be slim to none. It is becoming exponentially more difficult to attain patent protection in the majority of these areas, and inventors have to think ahead and consider alternative paths and strategies to protect their portfolios.   Join us at American Conference Institute’s annual Advanced Summit on Life Sciences Patents and hear from our esteemed faculty as they provide analysis and insider viewpoints on the hottest, most pressing life-sciences topics. This year’s speaking faculty is comprised of senior-level executives from top pharmaceutical companies, leading outside counsel, members of the judiciary and present and former representatives from the PTO.   Fresh for this year, we have added several panels which will discuss: impacts of the new administration on patent reform and the development of life sciences inventions, the impact of the Halo decision and the new willfulness standard on life sciences patents, and a post-conference workshop on the offensive and defensive use of the inter partes review process.   To further networking opportunities, we will again be co-locating this event with our Medical Device Patents conference. Don’t sit back while your competition gains this valuable knowledge. Register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563 or registering online.   We look forward to seeing you in New York this spring. Very truly yours, Julie E. Kurzrok, Esq. Legal Analyst and Program Director American Conference Institute


Park Lane Hotel

36 Central Park S, New York, NY 10019